Sarcoma sinovial primario en pared costal / Chest wall synovial pleural sarcoma. A rare disease

El sarcoma sinovial pleural es una neoplasia de tejidos blandos muy rara. A pesar de su nombre, el tumor generalmente no muestra asociación con cavidades articulares y ha sido descrito en otras localizaciones no sinoviales. Presentamos el caso de un varón de 48 años con inicio de dolor agudo en hemitórax izquierdo, pleurítico, con una masa pleural de 7 cm en radiografía de tórax que tras el diagnóstico histológico mediante punción transtorácica inicia tratamiento quimioterápico y ante la ausencia de adecuada respuesta finalmente se realiza extirpación de éste mediante toracotomía y colocación de prótesis en pared torácica

Synovial pleural sarcoma is a very rare soft tissue neoplasm. Despite its name, the tumor usually shows no association with joint cavities and has been described in other non-synovial sites. We present the case of a 48-year-old man with acute pleuritic pain in left hemithorax, with a lung mass of 7 cm on chest radiography. After histological diagnosis by transthoracic puncture, he started chemotherapy treatment and, in the absence of adequate response, it is finally removed by thoracotomy and placement of thoracic wall prosthesis

Burden of serious fungal infections in Spain.

Estimates of the incidence and prevalence of serious fungal infections, based on epidemiological data, are essential in order to inform public health priorities given the lack of resources dedicated to the diagnosis and treatment of these serious fungal diseases. However, epidemiology of these infections is largely unknown, except for candidaemia and cryptococcosis. The aim of this work is to calculate the burden of serious fungal infections in Spain. All published epidemiology papers reporting fungal infection rates from Spain were identified. Where no data existed, we used specific populations at risk and fungal infection frequencies in those populations to estimate national incidence or prevalence, depending on the condition. Around 8.1 million people suffer a fungal infection every year. Most of them are skin or mucosal infections causing no deaths. Candidaemia is more common than in other European countries and has risen by 1.88-fold in frequency in the last decade (8.1 cases × 100,000). Good estimates of invasive aspergillosis (2.75 cases × 100,000) and mucormycosis (0.04 × 100,000) are available. Fungal infections with a high mortality such as invasive aspergillosis, candidaemia, Pneumocystis pneumonia and mucormycosis are not numerous in Spain, but they affect those with severe underlying diseases and are therefore linked to poor outcomes. Additional studies are required, especially for high burden diseases such as recurrent thrush in women (∼9000 cases × 100,000 women), allergic bronchopulmonary aspergillosis (126 cases × 100,000) and severe asthma with fungal sensitisation (198 cases × 100,000).